SCHEMBL9712503

SCHEMBL9712503

Cc1cc(F)c(C(=O)Cl)c(F)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
ALDH1A1 P00352 4/20 0.37
ALOX15 P16050 1/20 0.37
TPMT P51580 1/20 0.36
KMT2A Q03164 3/20 0.35
GAA P10253 2/20 0.35
SELL P14151 1/20 0.35
SELP P16109 1/20 0.35
SELE P16581 1/20 0.35
MEN1 O00255 2/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA4 P22748 2/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17791102 0.82 SMN1; SMN2 (0.35) HDAC1HDAC6ALDH1A1KMT2AMEN1
SCHEMBL289690 0.80 CES2 (0.44) ALDH1A1ALOX15KMT2AGAACA1
SCHEMBL2397770 0.78 ALDH1A1 (0.41) ALDH1A1ALOX15TPMTKMT2AGAA
SCHEMBL6192702 0.78 CYP3A4 (0.41) HDAC1HDAC6TPMTKMT2ASELL
SCHEMBL290102 0.78 TPMT (0.48) HDAC1HDAC6ALDH1A1TPMTKMT2A
SCHEMBL24203431 0.77 HDAC1 (0.39) HDAC1HDAC6ALDH1A1ALOX15KMT2A
SCHEMBL12121150 0.76 POLB (0.41) HDAC1HDAC6TPMTKMT2ASELL
SCHEMBL1085223 0.76 DGAT1 (0.41) ALDH1A1ALOX15KMT2AGAAMEN1
SCHEMBL5506097 0.76 CA1 (0.43) HDAC1HDAC6ALDH1A1ALOX15CA1
SCHEMBL30417635 0.76 CA1 (0.43) HDAC1HDAC6ALDH1A1ALOX15CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160152561-A1 SULFONAMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS (SAN DIEGO) LLC 2016-06-02 US disclosed
US-5117057-A Insecticidal N' substituted-N-N'-disubstituted-hydrazines ROHM AND HAAS COMPANY (US) 1992-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160152561-A1 SULFONAMIDES AS MODULATORS OF SODIUM CHANNELS TRPV1, SCN1A, SCN5A HDAC1 682/4885HDAC6 242/4885ALDH1A1 1877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.